Phosphotransferases
- Name
- Phosphotransferases
- Accession Number
- DBCAT002921
- Description
A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.
- Drugs
Drug Drug Description Sitimagene ceradenovec Intended for the treatment of brain cancer. Nelipepimut-S Investigated for use/treatment in prostate cancer and breast cancer. Luspatercept An erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms. Dalantercept Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma). VEGFR2-169 VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)). TERT-572 Not Available - Drugs & Drug Targets
Drug Target Type Nelipepimut-S HLA class I histocompatibility antigen, A-2 alpha chain target Nelipepimut-S HLA class I histocompatibility antigen, A-3 alpha chain target